To test the functional consequences of the IKKε‐mediated metabolic rewiring on tumour proliferation, we assessed the outcome of inhibiting the two key metabolic reactions of serine biosynthesis on cell proliferation in a panel of breast cancer cell lines. The gene discussed is IKBKE; the disease is breast cancer.